[per loin]

I posted the above chart because it oddly coincides with a couple of interesting periods in SARS history. At the time of the initial outbreak in November, there is a spike of activity in Ligand shares, but they continue to drop in value until SARS escapes China, the low point on the chart. Since then they have climbed steadily. Does Ligand have a product in the SARS field?

[CobaltBlue]

Here's a link to Ligand's "pipeline" of drugs being developed. I don't see anything that would be useful against viral infections. My guess is that the increase in share prices is due to Targretin being approved for the treatment of non-small cell lung cancer.
http://www.ligand.com/products/pipeline.htm